Senzime AB (publ) - ESG Rating & Company Profile powered by AI
This ESG assessment for Senzime AB (publ) indicates the company's transparency towards the United Nations SDGs. Other companies in the rating peer group for Senzime AB (publ) are shownin the table. The page contains a questions and answers table on Senzime AB (publ).
Senzime AB (publ) in the Advanced Medical Equipment & Technology industry gained a UN SDG ESG Transparency Score of 6.6; made up of an environmental score of 5.3, social score of 6.4 and governance score of 8.0.
6.6
Medium ImpactEnvironmental
Social
Governance
![Detailed ESG Breakdown](/resource/detailed-esg.png?ts=1737978896147)
Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Calmark Sweden AB | 8.0 | High |
1 | CHC Healthcare Group | 8.0 | High |
55 | Uscom Ltd | 6.7 | High |
55 | Wellteq Digital Health Inc | 6.7 | High |
63 | Senzime AB (publ) | 6.6 | High |
63 | AGFA Gevaert NV | 6.6 | High |
63 | Fresenius SE & Co KGaA | 6.6 | High |
... | ... | ... | |
260 | Zhuhai Hokai Medical Instruments Co Ltd | 0.0 | Low |
260 | Zynex Inc | 0.0 | Low |
... | ... | ... |
![Peer Companies Benchmark](/resource/peer-benchmark-2.png?ts=1737978896147)
Frequently Asked Questions
Does Senzime AB (publ) have an accelerator or VC vehicle to help deliver innovation?
Does Senzime AB (publ) disclose current and historical energy intensity?
Does Senzime AB (publ) report the average age of the workforce?
Does Senzime AB (publ) reference operational or capital allocation in relation to climate change?
Does Senzime AB (publ) disclose its ethnicity pay gap?
Does Senzime AB (publ) disclose cybersecurity risks?
Does Senzime AB (publ) offer flexible work?
Does Senzime AB (publ) have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Senzime AB (publ) disclose the number of employees in R&D functions?
Does Senzime AB (publ) conduct supply chain audits?
Does Senzime AB (publ) disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Senzime AB (publ) conduct 360 degree staff reviews?
Does Senzime AB (publ) disclose the individual responsible for D&I?
Does Senzime AB (publ) disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Senzime AB (publ) disclose current and / or historical scope 2 emissions?
Does Senzime AB (publ) disclose water use targets?
Does Senzime AB (publ) have careers partnerships with academic institutions?
Did Senzime AB (publ) have a product recall in the last two years?
Does Senzime AB (publ) disclose incidents of discrimination?
Does Senzime AB (publ) allow for Work Councils/Collective Agreements to be formed?
Has Senzime AB (publ) issued a profit warning in the past 24 months?
Does Senzime AB (publ) disclose parental leave metrics?
Does Senzime AB (publ) disclose climate scenario or pathway analysis?
Does Senzime AB (publ) disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Senzime AB (publ) disclose the pay ratio of women to men?
Does Senzime AB (publ) support suppliers with sustainability related research and development?
Does Senzime AB (publ) disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Senzime AB (publ) reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Senzime AB (publ) involved in embryonic stem cell research?
Does Senzime AB (publ) disclose GHG and Air Emissions intensity?
Does Senzime AB (publ) disclose its waste policy?
Does Senzime AB (publ) report according to TCFD requirements?
Does Senzime AB (publ) disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Senzime AB (publ) disclose energy use targets?
Does Senzime AB (publ) disclose its Renewable Energy targets?
![Only Subscribers](/resource/reload.png)
Are emissions metrics verified by STBi?
![Only Subscribers](/resource/reload.png)
Does Senzime AB (publ) have a policy relating to cyber security?
Have a different question?
Potential Risks for Senzime AB (publ)
These potential risks are based on the size, segment and geographies of the company.
Senzime AB (publ), a medical device company, develops and markets patient monitoring systems to monitor patients under anesthesia in Europe, Oceania, Asia, Canada, and the United States. The company offers TetraGraph, a monitor that stimulates, measures, analyzes, and displays muscle function in surgical patients receiving neuromuscular blocking agents; TetraSens electrode array, which has two proximal stimulating electrodes for recording and reference; TetraConnect, a data management portal that helps clinician to access, view, and export data records from the TetraGraph in PDF or Excel format; TetraGraph Device Connectivity, which transfers data from the TetraGraph Monitor to patient monitoring systems; and TetraGraph Philips Interface that enables the transmission of neuromuscular monitoring parameters, TOFC, TOFR, PTC, and TOF bars to Philips patient monitors, as well as TetraGraph readings are displayed on the Philips Intellivue Monitor. It also develops CliniSenz Analyzer for postoperative and continuous patient monitoring in hospital environments; and Onzurf Probe, a sterile CE-marked single use product based on micro-dialysis technology that enables continuous sampling from gastro-intestinal organs, such as esophagus, stomach, and liver. Senzime AB (publ) has a strategic license and connectivity agreement with Masimo to develop and market the TetraGraph Smart Cable Module that connects directly to Root monitoring system, as well as to their digital hubs to interface with the hospital clinical information system/electronic health records. The company was incorporated in 1999 and is based in Uppsala, Sweden.